Surgery for Gastric and Oesophageal Cancer

Similar documents
Epidemiology, aetiology and the patient pathway in oesophageal and pancreatic cancers

National Oesophago-Gastric Cancer Audit New Patient Registration sheet Patients with Oesophageal High Grade Glandular Dysplasia

Jejunostomy after oesophagectomy, how and why I do it

Aliu Sanni MD SUNY Downstate Medical Center August 16, 2012

The Royal Marsden. Surgery for Gastric and GE Junction Cancer: primary palliative when and where? William Allum Consultant Surgeon

The Royal Marsden. Surgery for Gastric and GE Junction Cancer: primary palliative when and where? William Allum

Management of Esophageal Cancer: Evidence Based Review of Current Guidelines. Madhuri Rao, MD PGY-5 SUNY Downstate Medical Center

NICE guideline Published: 24 January 2018 nice.org.uk/guidance/ng83

Oesophagogastric Cancer The Patient s Pathway

ESOPHAGEAL CANCER. Dr. Paul Gardiner December 17, 2002 Discipline of Surgery Rounds

The Learning Curve for Minimally Invasive Esophagectomy

FTS Oesophagectomy: minimal research to date 3,4

Newly Diagnosed Cases Cancer Related Death NCI 2006 Data

Determining the Optimal Surgical Approach to Esophageal Cancer

Michael A. Choti, MD, FACS Department of Surgery Johns Hopkins Medicine, Baltimore, MD

Minimally Invasive Esophagectomy- Valuable. Jayer Chung, MD University of Colorado Health Sciences Center December 11, 2006

SETTING Fudan University Shanghai Cancer Center. RESPONSIBLE PARTY Haiquan Chen MD.

A 16 yr old boy with aggressive ca esophagus. DR Ayunga A.O Physician-Garisa PGH Associate Faculty Lecturer-UON Afya Bora Fellow in Global Health

SMALL BOWEL ADENOCARCINOMA. Dr. C. Jeske

GUIDELINE NUMBER: 87. Management of oesophageal and gastric cancer. DATE ISSUED: June 2006 CLINICAL SERVICES INVOLVED: Upper GI

Controversies in management of squamous esophageal cancer

APPLYING ENHANCED RECOVERY PRINCIPLES: EARLY TESTING IN UPPER GI CANCER

Tumours of the Oesophagus & Gastro-Oesophageal Junction Histopathology Reporting Proforma

DATA REPORT. August 2014

Oesophago gastric cancer the disease and the challenges. Muntzer Mughal

Gastrointestinal Tract Cancer

Upper GI Malignancies Imaging Guidelines for the Management of Gastric, Oesophageal & Pancreatic Cancers 2012

Medicinae Doctoris. One university. Many futures.

CT PET SCANNING for GIT Malignancies A clinician s perspective

MINIMALLY INVASIVE ESOPHAGECTOMY FOR CANCER: where do we stand?

The 1 st Oesophago gastric Cancer Centers Meeting for The Anglia Cancer Network

The following slides are provided as presented by the author during the live educa7onal ac7vity and are intended for reference purposes only.

Esophageal Cancer. Wesley A. Papenfuss MD FACS Surgical Oncology Aurora Cancer Care. David Demos MD Thoracic Surgery Aurora Cancer Care

Determining Resectability and Appropriate Surgery for Esophageal Cancer

Index. Note: Page numbers of article titles are in boldface type.

A review of the management of 100 cases of

Minimally Invasive Esophagectomy

Esophageal cancer: Biology, natural history, staging and therapeutic options

Stenting for Esophageal Cancer Technical Issues and Outcomes

Surgical Problems in Proximal GI Cancer Management Cardia Tumours Question #1: What are cardia tumours?

7/20/2017. Esophageal Cancer: A Less Common But Deadly Cancer. Objectives. Disclosure Statement NYNPA Conference October Saratoga New York

Surgical strategies in esophageal cancer

Management of oesophageal carcinoma

1. Epidemiology of Esophageal Cancer 2. Operative Strategies 3. Minimally Invasive Esophagectomy 4. Video

ESOPHAGEAL CANCER AND GERD. Prof Salman Guraya FRCS, Masters MedEd

Oesophageal Cancer: The Image after Surgery

BRANDON REGIONAL HEALTH CENTER; WHIPPLE S PROCEDURE AND ESOPHAGECTOMY AUDIT

Oesophageal Cancer: The Image after Surgery

Transhiatal Esophagectomy: Lower Mortality, Diminished Morbidity, Equal Effectiveness

Palliative side-to-side oesophagogastrostomy for

OESOPHAGO-GASTRIC CANCER 2016

Lek. Agnieszka Słowik Oddział Kliniczny Onkologii Collegium Medicum UJ

17. Oesophagus. Upper gastrointestinal cancer

Protocol for Planning and Treatment. The process to be followed when a course of chemotherapy is required to treat: UPPER GI CANCER

Case Scenario year-old white male presented to personal physician with dyspepsia with reflux.


Greater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy

National Oesophago-Gastric Cancer Audit Progress Report 2014

CLINICAL EFFECTIVENESS

Douglas G. Adler MD. ACG Regional Postgraduate Course - Nashville, TN Copyright 2013 American College of Gastroenterology

OPEN ACCESS TEXTBOOK OF GENERAL SURGERY

is time consuming and expensive. An intra-operative assessment is not going to be helpful if there is no more tissue that can be taken to improve the

Is a Metallic Stent Useful for Non Resectable Esophageal Cancer?

Resectable locally advanced oesophagogastric cancer

Gastro-oesophageal junction cancers (ICD10 C15.2, C15.5, C16.0) 1

Second Database Report. The Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland

Quiz Adenocarcinoma of the distal stomach has been increasing in the last 20 years. a. True b. False

Advances in gastric cancer: How to approach localised disease?

Perioperative chemotherapy: individualized therapy or same treatment for all? Prof. Dr. med. Salah-Eddin Al-Batran

DEPARTMENT OF ONCOLOGY ELECTIVE

Limited en bloc Resection of the Gastroesophageal Junction with Isoperistaltic Jejunal Interposition

Upper GI. Oesophageal & Gastric Cancer. Tumour Group: Regimen name / acronym Cisplatin/5-FU with concomitant RT. Place in therapy

Gastroesophag Gastroesopha eal Junction Adenocarcinoma: What is the best adjuvant regimen? Michael G. G. H addock Haddock M.D.

The following slides are provided as presented by the author during the live educa7onal ac7vity and are intended for reference purposes only.

Gastrointestinal pathology 2018 lecture 2. Dr Heyam Awad FRCPath

Minimally Invasive Esophagectomy

When to Refer for OGD and the Work Up of Upper GI Malignancies

NEOADJUVANT THERAPY IN CARCINOMA STOMACH. Dr Jyotirup Goswami Consultant Radiation Oncologist Narayana Superspeciality Hospital, Howrah

Guidelines for the management of oesophageal and gastric cancer

Which Treatment Approach is Most Appropriate for Primary Therapy of Gastric Cancer: Neoadjuvant Chemotherapy

POSTOPERATIVE COMPLICATIONS OF TRANSTHORACIC ESOPHAGECTOMY FOR ESOPHAGEAL CARCINOMA

Intended for use by Clinicians and Health Care Providers involved in the Management or Referral of adult patients with pancreatic

ADJUVANT CHEMOTHERAPY...

Gastroenterology Tutorial

THORACIC MALIGNANCIES

MOLECULAR AND CLINICAL ONCOLOGY 3: , 2015

National Oesophago-Gastric Cancer Audit

Implementing PAthways for Early Diagnosis (I-PACED)

PANCREATIC CANCER GUIDELINES

SECTION 1: INCLUSION, EXCLUSION & RANDOMISATION INFORMATION

Paraoesophageal Hernia

سرطان المعدة. Gastric Cancer حمود حامد

When Stomach is Not Available

MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER

Locally Advanced Colon Cancer. Feiran Lou MD. MS. Richmond University Medical Center Department of Surgery

RTC Dec Felicitas Koller and Eric Grogan

Appendix 1: Regional Lymph Node Stations for Staging Esophageal Cancer

Pancreatic Cancer Where are we?

Early View Article: Online published version of an accepted article before publication in the final form.

AATS Focus on Thoracic Surgery: Minimally Invasive Esophagectomy: Are We Still Getting Better in 2017?

Transcription:

Surgery for Gastric and Oesophageal Cancer

Trends in cancer mortality, England and Wales SMR base 1980

Oesophago-Gastric Cancer The National Problem 5 th commonest malignancy 4 th commonest cause of death 13,500 people in 2010 5 year survival - oesophageal 10% 5 year survival - gastric 15%

Oesophago-Gastric Cancer The Local Problem North Trent Cancer Network Population 1.8m 30 October 2007 30 June 2009 744 cases of oesophagogastric cancer 155 resections (21%) 1 year survival Resected 77% Palliative oncology 34% Best supportive care 18%

Symptoms Physical signs Dysphagia Vomiting GI bleed Symptoms of anaemia Weight loss Dyspepsia Reflux

Epidemiology Marked increase in the incidence of lower 1/3 oesophageal and G-O junction adenocarcinoma in last 20 years Corresponding decrease in the incidence in distal gastric cancer and squamous cell cancer of the oesophagus.

Oesophageal Cancer Aetiology Smoking Alcohol G-O reflux Barrett s oesophagus

Why?

Medically fit No metastases Resectable Medically unfit Metastases Unresectable Operate Palliate

11

Restore Swallowing

Surgical Approaches Thoraco abdominal Left thoracic Right thoracic (Ivor-Lewis) McKeown (3-Stage) Transhiatal 14

Oesophageal Replacement Stomach (+/- pyloroplasty) Jejunum Colon (which segment?) Which route? 16

24

25

20

26

MRC trial OEO2 Resectable Oesophageal Carcinoma SCC / ACA Randomised Chemotherapy + Surgery (CS) Surgery alone (S) n=400 n=402

Kaplan-Meier curve showing survival from date of randomisation CS S p=0.004 OE 02 Trial

Oesophageal Carcinoma Conclusions Incidence is increasing Selection of patients for surgery has improved Peri operative mortality rate has fallen Expandable metal stents have improved palliative treatment for unresectable carcinomas Use of neoadjuvant treatments may improve survival rates Long term outcome for patients with oesophageal carcinoma remains dismal

29

CDH1 Family Tree Familial Diffuse Gastric Cancer 48 39 39 37 36 48

Aetiology of Gastric Cancer Napoleon Bonaparte 1769-1821 Diet: Full of salt preserved foods, very little fruit & vegetables common foods for long military campaigns Genetic: father died of stomach cancer H.Pylori: Chronic H.Pylori infection Pre cancerous changes: CAG

Gastric Cancer : Problems Late diagnosis Few curative resections Low 5 year survival High operative mortality Little specialisation

LAPAROSCOPY Peritoneal metastases Direct invasion of other organs Avoids open / close laparotomy Better surgical planning Anaesthetic assessment

DISTAL TUMOURS Stenosis Bleeding» Surgery

Gastric Resections Roux-en-Y 52

36

Lymphadenectomy 53

MAGIC Trial UK MRC Adjuvant Gastric Infusional Chemotherapy E epirubicin 3 cycles pre op C cisplatin 3 cycles post op F 5-FU

MAGIC Trial 1994-2000 503 patients Chemo & surgery 250 Surgery 253

MAGIC Trial Disease free survival Chemo-Surgery- Chemo Surgery 2 years 48% 40% 5 years 36% 23%

Gastric Cancer - Conclusions Incidence decreasing Pre-operative chemotherapy improves survival Better surgical results in specialist units Early diagnosis essential

Complications! 42

Pulmonary Complications Pain and atelectasis Impaired movement of diaphragm Extensive lymphadenectomy resulting in a form of acute pulmonary oedema Post chemotherapy/ irradiation bronchiolitis 43

Management Thoracic epidural combined with morphine PCA Early extubation or overnight ventilation? CPAP or not? Fluid restrict? 44

Anastomotic leak Early < 72 hours - technical. Re-exploration and repair Late > 1 week reflects local ischaemia +/or tension in anastomotic site. Manage conservatively. 45

Prevention of complications Pain control respiratory care and physio and nebulisers fluid balance inotropes versus vasoconstrictors nutrition with feeding jejunostomy? Manage on HDU or ITU 46

Oesophageal Carcinoma

Oesophageal Carcinoma

Oesophageal Carcinoma

Oesophageal Carcinoma

51

52

53